Product correctly added to cart.

discount label
Nevanimibe
View 3D

Biosynth logo

Nevanimibe

CAS: 133825-80-6

Ref. 3D-IFA82580

50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Friday 27 Dec 2024

Product Information

Name:
Nevanimibe
Synonyms:
  • Damp-cmumep
  • N-(2,6-Bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea
  • Urea, N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-dimethylamino)phenyl)cyclopentyl)methyl)-
  • 1-({1-[4-(Dimethylamino)Phenyl]Cyclopentyl}Methyl)-3-[2,6-Di(Propan-2-Yl)Phenyl]Urea
Description:

Nevanimibe is a fatty acid that has been shown to have a metabolic effect on humans. This drug binds to the mitochondrial membrane and inhibits the release of cytochrome c, which eventually leads to apoptosis. Nevanimibe also reduces the mitochondrial membrane potential and ATP levels in cells, which can lead to an increase in body mass index. Nevanimibe has been used for the treatment of adrenocortical carcinoma and has been found to be effective for long-term efficacy. It has also shown anti-inflammatory effects by inhibiting prostaglandin synthesis.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
421.62 g/mol
Formula:
C27H39N3O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IFA82580 Nevanimibe

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".